BIOPHTA
PrivateLast Round
Seed
Jun 3, 2024
Total Funding Raised
$7.84M
Company Overview
BIOPHTA is a preclinical-stage biotech company developing a technology for the treatment of eye diseases. Its ophthalmic insert technology is a mini-tablet that transforms into a hydrogel on the eye's surface, providing a continuous, controlled low dose of a drug for seven days.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIOPHTA Comparables
Compare BIOPHTA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EyeDura Therapeutics | 77% | |
| MediPrint Ophthalmics | 76% | |
| Synakis | 70% | |
BIOPHTA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 3, 2024 | ||||
| Pre Seed | May 20, 2021 | ||||
| Accelerator | Oct 18, 2020 |
Key People
Founding team and executive leadership
BIOPHTA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GO Capital | Seed |
| Sofimac Investment Managers | Seed |
| Mérieux Equity Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors grew 110% MoM, reaching 1.1K.
- Jan 22, 2025
Grew 60% QoQ from 5 to 8 employees.
BIOPHTA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BIOPHTA's valuation, stock price, and market status.